Immunomedics, Inc. to Present At Oppenheimer 19th Annual Healthcare Conference

MORRIS PLAINS, N.J., Oct. 30, 2008 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that Cynthia L. Sullivan, President and Chief Executive Officer, will provide a corporate overview at the Oppenheimer 19th Annual Healthcare Conference in New York. The presentation, scheduled on November 4, 2008 at 4:00 p.m., can be downloaded simultaneously at http://www.immunomedics.com/1aboutus/present.pdf.
MORE ON THIS TOPIC